Int. Journal of Clinical Pharmacology and Therapeutics, Volume 62 (2024) - February (96 - 100)

Methylobacterium infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review

Huiyi Wu, Huanhao Chen, Wenfeng Wu, Ping Zheng, Yilei Li
Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China

Add to Cart  

 

DOI 10.5414/CP204483

Abstract

Clinical pharmacists participated in the drug therapy of peritonitis caused by Methylobacterium infection in a patient with renal insufficiency. Based on the knowledge of clinical pharmacy, the patient’s condition and laboratory parameters, the literature, and the pharmacokinetic/pharmacodynamic characteristics of antibiotics, amikacin in combination with ciprofloxacin was suggested for anti-infection therapy. During the treatment, clinical pharmacists timely evaluated the efficacy of antibiotics, monitored the adverse reactions, and provided individualized pharmaceutical care in the patient.

Author Details

Authors

Departments

  • Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China

Address

Yilei Li, PharmD
Department of Pharmacy, Nanfang Hospital
Southern Medical University
Guangzhou Da Dao Bei 1838#
Baiyun District, Guangzhou, 510515 China
Email: [email protected]

Citation

Huiyi Wu, Huanhao Chen, Wenfeng Wu, Ping Zheng, Yilei Li.Methylobacterium infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review
. Int J Clin Pharmacol Ther. 2024; 62: 96-100. doi: 10.5414/CP204483. Pubmed: https://pubmed.ncbi.nlm.nih.gov/37997944/; PMID: 37997944.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart